← SynDRA
OGLEMILAST
SynDRA canonical compound SYN0039666 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PDE4A INHIBITOR
- Phosphodiesterase 4 inhibitor
- PDE4D INHIBITOR
- PDE4B INHIBITOR
- PDE4C INHIBITOR
- phosphodiesterase inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- AURKA
- BRD4
- BRPF1
- CDK2
- CSNK1D
- FGFR2
- GSK3B
- HDAC6
- MAPK1
- TRIM24
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- COMT
- CP2C9
- CP2D6
- CP3A7
- GAMT
- GNMT
- HNMT
- KSYK
- NNMT
- PNMT
- SYK
Cross-references
Synonyms
- GRC 3845
- GRC-3886
- Oglemilast (oral, COPD/asthma), Glenmark
- GRC 3886
- GRC3886
- oglemilastum
- RefChem:167982
- Oglemilast [INN]
- UNII-67GXQ6WCC6
- C20H13Cl2F2N3O5S
- OGLEMILAST [WHO-DD]
- SCHEMBL220245
- orb1706883
- SCHEMBL29369504
- SCHEMBL29413215
- YQF1369
- OKFDRAHPFKMAJH-UHFFFAOYSA-N
- AKOS016005519
- CS-0844
- FO65110
- NCGC00379066-01
- DA-56402
- HY-15178
- MS-29580
- NS00072956
- F84855
- T16379
- BRD-K92303087-001-01-6
- أوغليميلاست
- Oglemilast Sodium
- RefChem:928142
- oglemilast sodium
- SCHEMBL29496614
- 0J3S7PC0H3
Look up OGLEMILAST in the interactive SynDRA portal →